Adoptive transfer of invariant natural killer T (iNKT) cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adoptive transfer of invariant natural killer T (iNKT) cells, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC [Phase 1]